Oruka Therapeutics Inc
ORKA
NASDAQ
Biotechnology
$111.04
USD
+2.92 (+2.70%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $7.11B
Volume 1.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ORKA | Oruka Therapeutics Inc | $7.11B | - | - | - | |
SRRK | Scholar Rock Holding Corp | $6.66B | - | - | - | |
CAI | Caris Life Sciences Inc | $6.61B | 62.90 | +38.5% | - | |
ERAS | Erasca Inc | $6.29B | - | - | - | |
DNTH | Dianthus Therapeutics Inc | $6.19B | - | -60.8% | - | |
PTCT | PTC Therapeutics Inc | $6.06B | - | -42.8% | - | |
TVTX | Travere Therapeutics Inc | $5.74B | - | +77.1% | - | |
ACAD | ACADIA Pharmaceuticals Inc | $5.07B | 13.34 | +47.0% | - | |
DYN | Dyne Therapeutics, Inc | $4.95B | - | - | - | |
CELC | Celcuity Inc | $4.36B | - | - | - |
Top Peer by Growth
CG Oncology Inc
+1030.3% YoY Revenue
Lowest P/E Ratio
TG Therapeutics Inc
16.62x P/E
Best 1-Year Return
Oruka Therapeutics Inc
+605.3% Return